Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs. |
|
| Page No 1 2 3 4 5 6 7 8 9 10 11 |
| Phrase | Consultant | Town | Special Interests |
| acute oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, acute oncology, metastatic spinal cord compression |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, kidney cancer, prostate cancer, bladder |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, acute oncology, cancer of unknown primary, upper gastrointestinal cancer |
| acute oncology | *Consultant(s)* | *Towns* | Leukaemia, medical education, acute oncology |
| acute oncology | *Consultant(s)* | *Towns* | Clinical oncology, acute oncology, breast cancer |
| acute oncology | *Consultant(s)* | *Towns* | Gastrointestinal cancer, hepatobiliary cancer, acute oncology, communication skills training |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, acute oncology |
| acute oncology | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, cancer of unknown primary, acute oncology |
| Adult ocular oncology | *Consultant(s)* | *Towns* | Adult ocular oncology |
| Anaesthesia for head and neck oncology | *Consultant(s)* | *Towns* | Anaesthesia for head and neck oncology, anaesthesia for maxillofacial and craniofacial surgery, TIVA - total intravenous anaesthesia, difficult airway management |
| breast oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, urological oncology, breast oncology |
| breast oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, breast oncology |
| chest oncology | *Consultant(s)* | *Towns* | Paediatric radiology, cross-sectional imaging, chest oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology, breast cancer, lung cancer, sarcoma, teenage and young adult oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast malignancies, urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, upper gastrointestinal cancer including small bowel cancer, hepatopancreatobiliary cancer - liver, pancreas, bile duct, gallbladder, stereotactic ablative body radiotherapy - SABR |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, thyroid cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, ENT cancer, non-melanomatous skin cancer, proton beam therapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological cancers, testicular cancers, colorectal cancers |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, skin cancer, urological cancer, central nervous system cancers, thyroid cancer, radiotherapy, chemotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer - Intensity Modulated Radiotherapy - IMRT, head and neck cancer -proton beam radiotherapy, olfactory neuroblastoma and sionnasal tumours are a special interest, stereotactic ablative body radiotherapy - SABR |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, nonmelanoma skin cancers, stereotactic ablative body radiotherapy - SABR, brachytherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, radiotherapy for lymphoma, urological oncology, gastrointestinal cancer, chemotherapy, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, urological oncology, breast oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, prostate cancer, cancer genetics |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer, central nervous system tumours, urological malignancy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, gynaecological cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, hepatobiliary cancer, lung cancer, gastrointestinal tumours, oesophagogastric cancer, colorectal and anal cancer, pancreatic cancer, stereotactic body radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, skin, head and neck oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, immunotherapy, stereotactic ablative radiotherapy, chemotherapy, breast cancer, hormone therapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological cancer, gynaecological cancer, breast cancer, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, skin cancer, radiotherapy, immunotherapy, salivary gland cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lymphoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate, bladder, penile and kidney cancers, testicular cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancers, skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, melanoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, intensity modulated radiotherapy - IMRT, prostate brachytherapy, bladder cancer, testicular cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gastrointestinal cancer, lung cancer, skin cancer, thyroid cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lymphomas, gastrointestinal cancer, lung cancer, skin cancer, PET scanning in oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancers, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, cancer research, melanoma, skin cancers, immunotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancers, urological cancers, intensity modulated radiotherapy - IMRT, LDR/HDR prostate brachytherapy, image-guided gynaecological brachytherapy, chemotherapy for urological cancers - prostate, kidney, urinary bladder, chemotherapy and novel agents for gynaecological cancers - ovary, uterus, cervix, vulva, emergency radiotherapy for oncological emergencies, VMAT - volumetric modulated arc therapy and image-guided radiation therapy - IGRT for prostate and pelvic malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, soft tissue and bone sarcomas, gastrointestinal stromal tumours - GIST, oropharyngeal cancer, head and neck sarcomas, prostate cancer, bladder cancer, late radiotherapy toxicity, survivorship - resilience for patients |
| Page No 1 2 3 4 5 6 7 8 9 10 11 |
|
|
|
|
